Health claims made by influential entrepreneurs ahead of peer review pose ethical challenges. Discuss.

Peer review is how science checks its own work. When a well-known founder announces health benefits before that check, as in the recent debate over the "Temple" brain-health wearable, the public trusts the person in place of the evidence. This raises ethical questions of integrity, harm and accountability.

The legitimate side of founder-led claims

• Entrepreneurs can speed up innovation, pay for costly research and draw public attention to neglected problems such as dementia in an ageing India.
• Sharing early data openly can be a form of transparency, but only if it is clearly labelled as provisional.

Ethical challenges

• Scientific integrity: Fame takes the place of evidence (authority bias). A plausible link, such as brain blood flow and cognitive decline, gets sold as a proven diagnostic tool.
• Non-maleficence (do no harm): False alarms cause anxiety and lead to costly scans. False reassurance can lead people with early disease to put off seeing a doctor.
• Informed consent: Buyers cannot meaningfully consent to a product whose accuracy nobody knows.
• Conflict of interest: The person making the claim often profits from it, so advocacy and marketing become hard to tell apart.
• Mental privacy: Head-worn devices collect sensitive data around the clock. UNESCO's 2025 Recommendation on the Ethics of Neurotechnology covers even indirect neural data and calls for bans on commercial targeting of people during sleep [3].
• Regulatory arbitrage: The Medical Devices Rules, 2017 apply only to devices notified as "drugs" under the Drugs and Cosmetics Act, 1940 [1]. A "wellness" label can therefore keep a product away from CDSCO scrutiny.
• Equity: Premium gadgets widen the health-tech divide and pull attention away from public screening.

Way forward

• Pass a separate medical devices law with a National Commission on Medical Devices, as the Parliamentary Standing Committee on Health recommended in its 138th Report (2022) [1]. Separate device legislation has been on the agenda since a 2013 amendment bill [2].
• Define in law when a wellness claim becomes a medical claim.
• Require disclosure: label devices as "unvalidated" until peer-reviewed comparisons with standard methods such as MRI are published.
• Frame neural-data rules using UNESCO's framework [3], alongside the DPDP Act, 2023.
• Founder ethics: influence brings responsibility, so evidence should come before publicity.

Entrepreneurship and science can work together if evidence comes before publicity. Validation, honest labelling and a modern device law would turn influence into a force for public health. This reflects the fundamental duty of scientific temper under Article 51A(h) and the goals of SDG 3.